Explore our Website
The Knowledgebase is an online resource where you can search for information about allergy.
Around one third of the UK population (approximately 19 million people) will develop an allergy at some time in their lives.
Join us as a member of the Anaphylaxis Campaign today and help us to raise the profile of severe allergy and support those who live with life threatening allergies.
Topics of Interest
It’s not uncommon for those with allergies to be anxious about travelling abroad. However, by following our tops tips, going on holiday can be a lot less frightening. Read more…
We hope that schools will use these resources, ranging from presentations to AllergyWise courses, to help raise allergy awareness with their staff and pupils. Read more…
For parents and carers of food allergic children, Halloween can be a time of additional anxiety. We have a number of tips on how to stay safe during the spooky season. Read more…
Please donate today to help us provide free services for people in need of advice and support
14th October 2019
We have received the following statement from Bausch + Lomb regarding the supply status of AAIs: Bausch + Lomb is committed to helping ensure that patients have access to the medicines they need, and we are working diligently to help supply the market with this critical medicine. Over the last year we have seen a […]
8th October 2019
Information on the scope of the new Allergy Labelling legislation was scheduled to be published by the FSA on the 1st October 2019 but due to Industry stakeholders raising further questions concerning the new rules, the FSA have decided to defer issuing information on the scope of the new legislation in order to provide more […]
3rd October 2019
Thursday 3rd October 2019 The Medicines & Healthcare products Regulatory Agency (MHRA) has received reports of Emerade pens failing to activate. This means that the needle is not released, and the injection is not delivered. This is different from the needle blockage issue that you are likely to have been informed about previously by your […]
IMPORTANT UPDATE: Extended Use-by Period for Specific Lots of Jext® 150mcg and 300mcg Adrenaline Auto-Injectors
2nd October 2019
To support and maintain an overall adequate supply, ALK has obtained acceptance from the UK medicines regulator, MHRA, to extend the use of specific lot (batch) numbers of Jext® 150 mcg and Jext® 300 mcg auto-injectors, beyond the labelled expiry date by four months. The affected lot numbers are listed in the link below. Click […]